SINGAPORE EPILEPSY FOUNDATION

Business Description

SINGAPORE EPILEPSY FOUNDATION is registered as a business entity on 30 December 1994 (30.2 years ago) structured as a Public Company Limited By Guarantee (Local Company) with 6 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 199409591D. The business official address is located at 149 Rochor Road #04-06, Fu Lu Shou Complex, Singapore 188425 with main trading activity as Authoritative & Advisory Body For People With Epilepsy in the primary industry of 94120: Activities Of Professional Membership Organisations (eg Medical Associations, Law Societies, Accountancy Bodies) using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as SINGAPORE EPILEPSY CENTRE. The business annual account filing date falls on 31 July and is currently operational with the status of 'Live Company'.

In the past 365 days, SINGAPORE EPILEPSY FOUNDATION has received a total of Login to view reported payment review(s). 14 were rated Good and Login to view were rated Poor. The latest review was made on 2023-07-14 and it was reported "Good". The aggregated good payment amount is equivalent to USD 2,814, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is currently active, it also signals positive financial standing. The appointment of SUHAIMI SALLEH & ASSOCIATES as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

SINGAPORE EPILEPSY FOUNDATION is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023